Miller Joseph M — SEC insider filings

SEC reporting owner CIK 1746372. 19 insider filings on record with FilingPulse; latest filed 2026-10-13.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2020-10-01 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aurinia Pharmaceuticals Inc. (AUPH)Chief Financial Officer101 leg · 1,000 sh · $9,7406 legs · 178,578 sh · $1,372,36514
Avalo Therapeutics, Inc. (AVTX)Director8——8
LB PHARMACEUTICALS INC (LBRX)Chief Financial Officer1——1

Insider filings — Miller Joseph M

FiledFormIssuerReported transactionsSource
2026-10-134LB PHARMACEUTICALS INC (LBRX)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2026-03-034Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 57,229 @ $0 · Tax withholding (F): 37,511 @ $14.21 · Grant/award (A): 95,700 (derivative) @ $0EDGAR
2026-02-234Aurinia Pharmaceuticals Inc. (AUPH)Tax withholding (F): 32,424 @ $14.40EDGAR
2026-01-054Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 49,038 @ $0 · Tax withholding (F): 40,161 @ $15.95EDGAR
2025-03-044Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 81,457 @ $0 · Grant/award (A): 114,711 @ $0 · Sale (S): 61,859 @ $8 · Sale (S): 56,154 @ $7.92 · Grant/award (A): 124,393 (derivative) @ $0EDGAR
2024-03-074Aurinia Pharmaceuticals Inc. (AUPH)Sale (S): 34,811 @ $5.60EDGAR
2024-02-224/AAurinia Pharmaceuticals Inc. (AUPH)Sale (S): 11,398 @ $8.78EDGAR
2024-02-224Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 196,153 @ $0EDGAR
2023-03-064Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 229,421 · Sale (S): 11,296 @ $8.94EDGAR
2022-04-044Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 20,239 (derivative) @ $0EDGAR
2022-03-044Aurinia Pharmaceuticals Inc. (AUPH)Grant/award (A): 8,500 @ $0 · Sale (S): 3,060 @ $12.01 · Grant/award (A): 104,080 (derivative) @ $0 · Grant/award (A): 178,063 (derivative) @ $0EDGAR
2022-01-044Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 8,920 (derivative) @ $0EDGAR
2021-10-044Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 6,939 (derivative) @ $0EDGAR
2021-07-024Cerecor Inc. (CERC)Grant/award (A): 4,620 (derivative) @ $0EDGAR
2021-06-174Cerecor Inc. (CERC)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2021-05-114Aurinia Pharmaceuticals Inc. (AUPH)Purchase (P): 1,000 @ $9.74EDGAR
2021-04-024/ACerecor Inc. (CERC)Grant/award (A): 5,564 (derivative) @ $0EDGAR
2021-01-054Cerecor Inc. (CERC)Grant/award (A): 5,472 (derivative) @ $0EDGAR
2020-10-014Cerecor Inc. (CERC)Grant/award (A): 6,374 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1746372 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs